Connor, Clark & Lunn Investment Management Ltd. - VIKING THERAPEUTICS INC ownership

VIKING THERAPEUTICS INC's ticker is VKTX and the CUSIP is 92686J106. A total of 185 filers reported holding VIKING THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.42 and the average weighting 0.1%.

Quarter-by-quarter ownership
Connor, Clark & Lunn Investment Management Ltd. ownership history of VIKING THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$845,305
-73.6%
76,360
-61.3%
0.00%
-75.0%
Q2 2023$3,200,032
+112.5%
197,411
+118.3%
0.02%
+100.0%
Q1 2023$1,505,593
+81.5%
90,426
+2.5%
0.01%
+60.0%
Q4 2022$829,512
+17.3%
88,246
-66.0%
0.01%0.0%
Q3 2022$707,000
+9.8%
259,887
+16.6%
0.01%
+25.0%
Q2 2022$644,000
+80.9%
222,862
+87.7%
0.00%
+100.0%
Q1 2022$356,000
+97.8%
118,706
+202.8%
0.00%
+100.0%
Q4 2021$180,000
+20.0%
39,199
+63.7%
0.00%0.0%
Q3 2021$150,000
+78.6%
23,950
+70.9%
0.00%
Q2 2021$84,00014,0110.00%
Other shareholders
VIKING THERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
APIS CAPITAL ADVISORS, LLC 148,000$1,638,3602.12%
Sio Capital Management, LLC 595,002$6,586,6722.04%
5AM Venture Management, LLC 585,000$6,475,9501.86%
Artia Global Partners LP 383,580$4,246,2311.76%
Integral Health Asset Management, LLC 800,000$8,856,0001.23%
Boxer Capital, LLC 2,000,000$22,140,0001.18%
DAFNA Capital Management LLC 319,655$3,538,5811.10%
Affinity Asset Advisors, LLC 332,600$3,681,8821.04%
MPM BioImpact LLC 325,000$3,597,7500.96%
Affinity Asset Advisors, LLC 300,000$3,321,0000.93%
View complete list of VIKING THERAPEUTICS INC shareholders